| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |